Great progress in three new heavy drugs of HongRi pharmaceutical industry
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In fact, due to the speed of new drug evaluation, the speed of a new anti-cancer drug PTS and a new vascular drug fondaparinux is relatively slow PTS has been applied for production in the third quarter of last year, but it has been staying at the level of Tianjin pharmaceutical regulatory bureau; for fondaparinux, the company's impact on the first imitation has been temporarily behind, and Hengrui pharmaceutical and Huadong pharmaceutical have successively applied for production In response, the company's executives said, "at present, we are in a hurry, but we can only wait patiently." Among them, the synthesis process of fondaparinux sodium is very difficult At present, the company has completed the preparation and synthesis process research, and is in the process of stability inspection KB project is a new drug for the treatment of sepsis category 1 It cooperates with Xuebijing injection, the company's main product, to deepen the field of sepsis treatment.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
